[236] reported the involvement of TET2 in the demethylation and overexpression of c‐Maf‐inducing protein, which further induced the upregulation of guanylate binding protein 2/PPARγ/CD36 axis, accelerating the progression of NAFLD. The gene discussed is TET2; the disease is metabolic dysfunction-associated steatotic liver disease.